Summary
StartUp Health community member Dr. Codi Gharagouzloo, Chief Science Officer at Imaginostics, discusses their mission to establish a new vascular imaging technology as a global standard for early detection, treatment, and therapeutic development in Alzheimer's and vascular diseases. He emphasizes the value of the Alzheimer's Moonshot Community in securing clinical partnerships, specifically highlighting a study with 96 participants.
Highlights
🧠 Moonshot Mission: Imaginostics aims to make a new vascular imaging technology the standard for early Alzheimer's and vascular disease detection, treatment, and therapy development.
🤝 Alzheimer's Moonshot Impact: Being part of the Alzheimer's Moonshot Community facilitated a critical clinical partnership with Dr. Phyllis Ferrell, leading to a study involving 96 participants.
📊 Significant Milestone: The 96-participant Alzheimer's and dementia study represents one of the key achievements in their mission.
*References to critical partnerships reflect ongoing discussions and anticipated collaborations that are not yet finalized.
Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is available to StartUp Health Members. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
👉 Learn more and join today.
